Amgen Won't Face 'Nonsensical' Rodent Antibody IP At Trial
A Delaware federal judge has trimmed Harbour Medical's infringement suit against an Amgen unit just days before trial, saying two of the company's mouse antibody patents are indefinite based on a...To view the full article, register now.
Already a subscriber? Click here to view full article